Join the club for FREE to access the whole archive and other member benefits.

3D printing: risks vs. benefits for the pharma industry

3D printing is expensive right now but it may promote decentralization of some healthcare aspects

29-May-2018

Key points from article :

Prices coming down - more so for printers than inks.

3D printed pills are still being researched.

Opportunities include:

Faster pre-clinical evaluation of new drugs

New formulations

Precision/personalised medicine

Local manufacture

Topics mentioned on this page:
3D Printing (Healthcare)